What it does
Supports the Accelerated Access Collaborative to identify highly transformative technologies and accelerate their access to the market.
What it doesn't do
- Offer market access support to technologies not selected for AAC support.
- Accept referrals from companies or individuals.
- Replace the usual regulatory and health technology assessment processes.
Information about technologies may be shared with select individuals such as experts (and are bound by NICE confidentiality agreements) or AAC partner organisations (covered by existing confidentiality arrangements in their own organisations) for the purpose of identifying relevant technologies.
The team will only review your information if it is referred to them by one of the AAC partner organisations. You will be contacted if your technology is going to be progressed by the AAC.